世界の癌胎児性抗原関連細胞接着分子5市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5646 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、癌胎児性抗原関連細胞接着分子5の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ETBX-011、Vbx-016、OSE-2101、GI-6207、その他）、用途別市場規模（転移性乳がん、転移性膵臓がん、腹膜がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・癌胎児性抗原関連細胞接着分子5の市場動向 ・企業の競争状況、市場シェア ・癌胎児性抗原関連細胞接着分子5の種類別市場規模と予測2016-2027（ETBX-011、Vbx-016、OSE-2101、GI-6207、その他） ・癌胎児性抗原関連細胞接着分子5の用途別市場規模と予測2016-2027（転移性乳がん、転移性膵臓がん、腹膜がん、その他） ・癌胎児性抗原関連細胞接着分子5の北米市場規模2016-2027（アメリカ、カナダ） ・癌胎児性抗原関連細胞接着分子5の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・癌胎児性抗原関連細胞接着分子5のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・癌胎児性抗原関連細胞接着分子5の中南米市場規模2016-2027（メキシコ、ブラジル） ・癌胎児性抗原関連細胞接着分子5の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Akshaya Bio Inc.、Celgene Corporation、Etubics Corporation、OSE Immunotherapeutics、Vaxon Biotech） ・結論

Market Analysis and Insights: Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market
The global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market.

Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Scope and Market Size
Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ETBX-011
Vbx-016
OSE-2101
GI-6207
Others

Segment by Application
Metastatic Breast Cancer
Metastatic Pancreatic Cancer
Peritoneal Tumor
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Akshaya Bio Inc.
Celgene Corporation
Etubics Corporation
OSE Immunotherapeutics
Vaxon Biotech

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ETBX-011
1.2.3 Vbx-016
1.2.4 OSE-2101
1.2.5 GI-6207
1.2.6 Others
1.3 Market by Application
1.3.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Metastatic Breast Cancer
1.3.3 Metastatic Pancreatic Cancer
1.3.4 Peritoneal Tumor
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Perspective (2016-2027)
2.2 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Growth Trends by Regions
2.2.1 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Historic Market Share by Regions (2016-2021)
2.2.3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Forecasted Market Size by Regions (2022-2027)
2.3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Industry Dynamic
2.3.1 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Trends
2.3.2 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Drivers
2.3.3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Challenges
2.3.4 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players by Revenue
3.1.1 Global Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players by Revenue (2016-2021)
3.1.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Players (2016-2021)
3.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue
3.4 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Concentration Ratio
3.4.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in 2020
3.5 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Key Players Head office and Area Served
3.6 Key Players Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Solution and Service
3.7 Date of Enter into Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Breakdown Data by Type
4.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Historic Market Size by Type (2016-2021)
4.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Forecasted Market Size by Type (2022-2027)

5 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Breakdown Data by Application
5.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Historic Market Size by Application (2016-2021)
5.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size (2016-2027)
6.2 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type
6.2.1 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021)
6.2.2 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027)
6.2.3 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2027)
6.3 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application
6.3.1 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021)
6.3.2 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027)
6.3.3 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2027)
6.4 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country
6.4.1 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2016-2021)
6.4.2 North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size (2016-2027)
7.2 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type
7.2.1 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021)
7.2.2 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027)
7.2.3 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2027)
7.3 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application
7.3.1 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021)
7.3.2 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027)
7.3.3 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2027)
7.4 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country
7.4.1 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2016-2021)
7.4.2 Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size (2016-2027)
8.2 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type
8.2.1 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2027)
8.3 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application
8.3.1 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2027)
8.4 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Region
8.4.1 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size (2016-2027)
9.2 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type
9.2.1 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021)
9.2.2 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027)
9.2.3 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2027)
9.3 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application
9.3.1 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021)
9.3.2 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027)
9.3.3 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2027)
9.4 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country
9.4.1 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2016-2021)
9.4.2 Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size (2016-2027)
10.2 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type
10.2.1 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2027)
10.3 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application
10.3.1 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2027)
10.4 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country
10.4.1 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Akshaya Bio Inc.
11.1.1 Akshaya Bio Inc. Company Details
11.1.2 Akshaya Bio Inc. Business Overview
11.1.3 Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Introduction
11.1.4 Akshaya Bio Inc. Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
11.1.5 Akshaya Bio Inc. Recent Development
11.2 Celgene Corporation
11.2.1 Celgene Corporation Company Details
11.2.2 Celgene Corporation Business Overview
11.2.3 Celgene Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Introduction
11.2.4 Celgene Corporation Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
11.2.5 Celgene Corporation Recent Development
11.3 Etubics Corporation
11.3.1 Etubics Corporation Company Details
11.3.2 Etubics Corporation Business Overview
11.3.3 Etubics Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Introduction
11.3.4 Etubics Corporation Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
11.3.5 Etubics Corporation Recent Development
11.4 OSE Immunotherapeutics
11.4.1 OSE Immunotherapeutics Company Details
11.4.2 OSE Immunotherapeutics Business Overview
11.4.3 OSE Immunotherapeutics Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Introduction
11.4.4 OSE Immunotherapeutics Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
11.4.5 OSE Immunotherapeutics Recent Development
11.5 Vaxon Biotech
11.5.1 Vaxon Biotech Company Details
11.5.2 Vaxon Biotech Business Overview
11.5.3 Vaxon Biotech Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Introduction
11.5.4 Vaxon Biotech Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
11.5.5 Vaxon Biotech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ETBX-011
Table 3. Key Players of Vbx-016
Table 4. Key Players of OSE-2101
Table 5. Key Players of GI-6207
Table 6. Key Players of Others
Table 7. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Regions (2016-2021)
Table 11. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Regions (2022-2027)
Table 13. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Trends
Table 14. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Drivers
Table 15. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Challenges
Table 16. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Restraints
Table 17. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Players (2016-2021)
Table 19. Global Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 as of 2020)
Table 20. Ranking of Global Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Solution and Service
Table 24. Date of Enter into Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Type (2016-2021)
Table 28. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Application (2016-2021)
Table 32. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size by Country (2022-2027) & (US$ Million)
Table 64. Akshaya Bio Inc. Company Details
Table 65. Akshaya Bio Inc. Business Overview
Table 66. Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product
Table 67. Akshaya Bio Inc. Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021) & (US$ Million)
Table 68. Akshaya Bio Inc. Recent Development
Table 69. Celgene Corporation Company Details
Table 70. Celgene Corporation Business Overview
Table 71. Celgene Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product
Table 72. Celgene Corporation Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021) & (US$ Million)
Table 73. Celgene Corporation Recent Development
Table 74. Etubics Corporation Company Details
Table 75. Etubics Corporation Business Overview
Table 76. Etubics Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product
Table 77. Etubics Corporation Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021) & (US$ Million)
Table 78. Etubics Corporation Recent Development
Table 79. OSE Immunotherapeutics Company Details
Table 80. OSE Immunotherapeutics Business Overview
Table 81. OSE Immunotherapeutics Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product
Table 82. OSE Immunotherapeutics Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021) & (US$ Million)
Table 83. OSE Immunotherapeutics Recent Development
Table 84. Vaxon Biotech Company Details
Table 85. Vaxon Biotech Business Overview
Table 86. Vaxon Biotech Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product
Table 87. Vaxon Biotech Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021) & (US$ Million)
Table 88. Vaxon Biotech Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Type: 2020 VS 2027
Figure 2. ETBX-011 Features
Figure 3. Vbx-016 Features
Figure 4. OSE-2101 Features
Figure 5. GI-6207 Features
Figure 6. Others Features
Figure 7. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Application: 2020 VS 2027
Figure 8. Metastatic Breast Cancer Case Studies
Figure 9. Metastatic Pancreatic Cancer Case Studies
Figure 10. Peritoneal Tumor Case Studies
Figure 11. Others Case Studies
Figure 12. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Report Years Considered
Figure 13. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Regions: 2020 VS 2027
Figure 16. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Regions (2022-2027)
Figure 17. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Players in 2020
Figure 18. Global Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in 2020
Figure 20. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Type (2016-2021)
Figure 21. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share by Type (2022-2027)
Figure 22. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Type (2016-2027)
Figure 24. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Application (2016-2027)
Figure 25. North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Country (2016-2027)
Figure 26. United States Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Type (2016-2027)
Figure 30. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Application (2016-2027)
Figure 31. Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Country (2016-2027)
Figure 32. Germany Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Region (2016-2027)
Figure 42. China Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Type (2016-2027)
Figure 50. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Application (2016-2027)
Figure 51. Latin America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Country (2016-2027)
Figure 52. Mexico Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Share by Country (2016-2027)
Figure 58. Turkey Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Akshaya Bio Inc. Revenue Growth Rate in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
Figure 62. Celgene Corporation Revenue Growth Rate in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
Figure 63. Etubics Corporation Revenue Growth Rate in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
Figure 64. OSE Immunotherapeutics Revenue Growth Rate in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
Figure 65. Vaxon Biotech Revenue Growth Rate in Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---